SRC and neoplasm: It is involved in the interaction between vascular endothelial growth factor receptor 2 (VEGFR2) and c-Rous sarcoma (c-Src), leading to c-Src activation and promotion of tumor vascular permeability (Matsumoto et al., 2005; Sun et al., 2012).